Vivera announced today that it has the solution to one of our nation’s most significant health challenges: the opioid crisis.
Three of America’s biggest pharmacy chains were recently found liable for helping to fuel the opioid crisis. Jurors decided that Walmart, CVS, and Walgreens, contributed to a public nuisance in two Ohio counties by selling and dispensing large quantities of prescription pain pills after it was evident addiction rates and overdoses were increasing as a result.
To date, opioids have taken the lives of hundreds of thousands of people since 1999. According to preliminary data released by the Centers for Disease Control and Prevention (CDC), more than 100,000 people died of a drug overdose in the U.S. between April 2020 and April 2021 alone, making it the first time that drug-related deaths have reached six figures in a 12-month period. Over 75 percent of the drug overdoses involved opioids.
“How many people have to die before they decide enough is enough? Money will not bring back the loved ones who have died from opioids, nor will it miraculously cure those struggling with addiction,” said Paul Edalat, CEO of Vivera. “The American people need a solution to the opioid crisis, not more lawsuits, and Vivera has that solution with ZICOH.”
ZICOH® is the Company’s prescription medication medical device designed to prevent prescription drug abuse and diversion. The device utilizes a unique database software that enables effective communication between patients, providers, caregivers, and pharmacists. ZICOH® also offers dose-controlled delivery, which allows the device to be programmed to administer the dosage type, amount, and frequency to patients according to the health care provider’s orders. Each of its features helps ensure patient compliance, reducing the risk of addiction and overdose.
A separate legal proceeding will determine how much the pharmaceutical companies, currently under the leadership of Doug McMillon, Rosalind Brewer, and Karen S. Lynch, will have to pay in reparations.
ZICOH is a secure, smart dosing device designed as part of a closed-loop medication management system backed by software and technology. Broadly patented for multiple applications, Vivera’s ZICOH device creates a centralized system to more safely manage and monitor prescription drug use, including for the use of medications with a historically low compliance rate or with a higher propensity for abuse. ZICOH’s features like dose-controlled delivery allow only the prescribed dosage type, amount, and frequency to be administered according to the health care provider’s orders. Additionally, fingerprint authentication ensures that the medication is dispensed to the person to whom it was prescribed.
Learn more about ZICOH® at Zicoh.com.